Perspective Therapeutics, Inc. (CATX) vs Electromed, Inc. (ELMD)

Perspective Therapeutics, Inc. and Electromed, Inc. are both Medical Devices companies. Perspective Therapeutics, Inc. is the larger, with a market value of $285.4M against $233.1M — 1.2× the size. Perspective Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Electromed, Inc. trades at 20.4×. Electromed, Inc. grew revenue faster over the last twelve months: 15.3% against −66.9%. Electromed, Inc. has the higher net margin (15.3% vs −28,468.0%) and the higher return on invested capital (25.9% vs −88.4%). Across the 19 metrics below, Electromed, Inc. leads on 16 and Perspective Therapeutics, Inc. on 3.

Valuation

Metric CATX ELMD Medical Devices median
P/E n/m 20.35 22.18
P/S 743.38 3.12 2.70
P/B 0.94 4.27 2.46
Price to free cash flow n/m 27.55 22.53
EV/EBITDA n/m 14.05 11.78
EV/Sales 167.98 2.85 2.38
Earnings yield (52.65%) 4.91% (8.22%)
Free cash flow yield (39.86%) 3.63% (7.80%)

Profitability

Metric CATX ELMD Medical Devices median
Gross margin 100.00% 78.54% 56.01%
Operating margin (30,619.07%) 18.82% (15.03%)
Net margin (28,467.97%) 15.32% (20.40%)
Free cash flow margin (29,630.07%) 11.34% (7.24%)
Return on equity (39.50%) 23.26% (15.32%)
Return on assets (33.14%) 18.82% (19.72%)
Return on invested capital (88.41%) 25.87% (10.33%)

Growth

Metric CATX ELMD Medical Devices median
Revenue growth (TTM) (66.88%) 15.28% 8.80%
EPS growth (last fiscal year) (13.82%) 52.94% —
Revenue growth, 5-year CAGR (38.04%) 15.59% 15.23%
Net income growth, 5-year CAGR 0.00% 36.76% 0.00%

Health

Metric CATX ELMD Medical Devices median
Debt to equity 0.00 0.00 0.07
Current ratio 6.61 4.69 2.50
Net debt to EBITDA 1.27 (1.37) 0.49

Dividend

Metric CATX ELMD Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric CATX ELMD Medical Devices median
Market cap 285.38m 233.08m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack